gainbot
BriefMoversScreensSectorsEarningsIPOsNewsDividends & splitsScreenerWatchlistLearn
NASDAQ · IRMDHealthcareSurgical Instruments

iRadimed Corporation (IRMD)

$88.58+9.21%
Close Nov 4, 2026 · split-adjusted
Oct 30, 2026$76.68▼ 0.17% in range
Oct 31, 2025Low $76.68 · High $105.15Oct 30, 2026
What changed · written from our data
As of Nov 4, 2026

iRadimed closed at $88.58 on Nov 4, up 9.21%, 15.8% below its 52-week closing high. Volume of 184.1K shares was 1.54× its 20-day average (above normal).

Split-adjusted performance: +4.4% over one month, +2.7% over six months, +5.3% over one year.

In the quarter ended Sep 30, 2026, revenue was $24.20M, up 14.2% from a year earlier, with a net margin of 26.9%.

Short interest was 670.2K shares at the Oct 15 settlement, up 1.9% from the prior report (8.1% of float, 6.2 days to cover).

Market cap$1.13B12.8M shares
Revenue · quarter$24.2M+14.2% YoY
Diluted EPS$0.51+18.6% YoY
P/E · TTM47.2×P/S 12.7×
Net margin26.9%Gross 76.3%
Dividend yield0.90%$0.2 last paid
52-week range76.68 – 105.15−15.8% from high
Volume184.1K1.54× 20-day avg
Volatility · 60d35.9%Annualised
Short % of float8.1%6.2 days to cover
Net cash$63.3MCash $63.3M
Next earnings—Not scheduled
Split-adjusted performance
1W +5.5%1M +4.4%3M −2.9%6M +2.7%YTD −8.9%1Y +5.3%3Y +120.9%5Y +154.5%

Earnings reactions

History →

No reported quarters with price history yet.

Rank within Surgical Instruments

Percentile among 110 companies (100 = best)

6-month momentum55
Revenue growth60
Net margin96
Value (low P/E)23
Size69

Industry medians: 6-month return −4.0%, revenue growth +8.9%, net margin −8.2%, P/E 30.5×.

Short interest

Details →
Shares short670.2K+1.9% vs prior
Days to cover6.2Settled Oct 15
% of float8.1%
Short vol. 10d42.9%of daily volume

Closest peers by size in Surgical Instruments

CompanyPriceToday6MRev. growthNet marginP/EMkt cap
IRMDiRadimed$88.58+9.21%+2.7%+14.2%26.9%47.2$1.13B
SIBNSI-BONE$24.95+4.96%+92.1%+15.2%−7.3%—$1.12BCompare
SGPSpyGlass Pharma$34.450.00%+37.5%———$1.15BCompare
IARTIntegra LifeSciences$14.82+8.73%+5.9%+2.3%3.6%88.6$1.15BCompare
PRCTPROCEPT BioRobotics$21.66+7.39%−12.7%+19.3%−28.4%—$1.24BCompare
ATECAlphatec Holdings$8.28+10.84%+18.5%+12.6%−2.5%—$1.27BCompare
AORTArtivion$26.45+11.56%−23.8%+11.3%−10.7%—$1.29BCompare
TNDMTandem Diabetes Care$19.05+7.93%+5.7%+5.8%−8.3%—$1.33BCompare
BBNXBeta Bionics$16.95+12.25%+60.4%+30.3%−68.6%—$921.5MCompare

News about iRadimed

All news →
IRadimed (IRMD) Q2 2026 Earnings Call TranscriptThe Motley Fool · Aug 8, 2026▲ PositiveIRADIMED's CEO Is Selling Steadily — The Plan, Not the Stock, Is Driving ItThe Motley Fool · Jun 2, 2026NeutralIradimed's CEO Dumped 7,500 Shares. Here's What That Means for Investors.The Motley Fool · Apr 28, 2026▲ PositiveIRADIMED CORPORATION to Participate at the 38th Annual Roth ConferenceGlobeNewswire Inc. · Mar 16, 2026▲ PositiveWhy Iradimed Stock Soared TodayThe Motley Fool · Feb 10, 2026▲ Positive

Quick answers

What does iRadimed do?
iRadimed Corp develops, manufactures, markets, and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them. The company provides a non-magnetic IV infusion pump system, which is designed to be safe for use during MRI procedures.
What is IRMD's market cap?
$1.13B, based on the Nov 4 close of $88.58.
What is IRMD's P/E ratio?
47.2× trailing-twelve-month earnings of $23.98M.
Does iRadimed pay a dividend?
Yes. The latest regular dividend was $0.2 per share (ex-date Aug 14), an annualised yield of 0.90%.
How much of IRMD is sold short?
670.2K shares, 8.1% of float, as of Oct 15, 2026.
What sector is IRMD in?
Healthcare, in the Surgical Instruments industry.

About iRadimed

iRadimed Corp develops, manufactures, markets, and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them. The company provides a non-magnetic IV infusion pump system, which is designed to be safe for use during MRI procedures. The MRI products of the company are sold to hospitals and acute care facilities in the United States and internationally. It generates the majority revenue from United States.

HQ: Orlando, FL166 employeesListed Jul 16, 2014iradimed.com

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology